Proton pump inhibitors (PPIs) are known to increase the risk for acute kidney injury and incident chronic...
Here is a look at recent developments and headlines in nephrology.
FDA Postpones Decision on Sparsentan in FSGS
The...
Proton pump inhibitors (PPIs) are known to increase the risk for acute kidney injury and incident chronic...
Here is a look at recent developments and headlines in nephrology.
The...
Health Canada has approved Ozempic to reduce the risk of further kidney decline among patients with Type...
Patients with a COVID-19 infection and acute kidney injury (AKI) who were vaccinated against SARS-CoV-2 had...